AI Summary
✦ ClarthaValuation Metrics
Trading 87.4% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +2.5). Confidence: 69%.
Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.
5Y Average
18.37
Current
41.36
Overvalued
29.05
Undervalued
16.36
5Y Average
11.82
Current
26.63
Overvalued
15.53
Undervalued
6.06
5Y Average
5.59
Current
5.76
Overvalued
6.42
Undervalued
4.65
Peers & Comparison
Sector: Materials · Theme: Commodity Chemicals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
HIMADRI SPECIALITY CHEM L HSCLCommodity Chemicals | +28.0% | 16.1% | 47.8x Premium | +26% vs avg | +59.5% |
GARWARE HI-TECH FILMS LTD GRWRHITECHCommodity Chemicals | +27.9% | 17.2% | 42.7x Fair | +13% vs avg | +145.7% |
INDIA GLYCOLS LTD INDIAGLYCOCommodity Chemicals | +13.1% | 7.0% | 22.8x Undervalued | -40% vs avg | +27.0% |
KINGFA SCI & TEC IND LTD. trades in line with peers (41.4x vs avg 37.8x), reflecting a fair valuation within the Commodity Chemicals cohort. Peers include HIMADRI SPECIALITY CHEM L, GARWARE HI-TECH FILMS LTD, INDIA GLYCOLS LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹578 CrMar 2026Latest net profit
₹59 CrMar 2026Latest EPS
₹43.65Mar 2026Net margin
14.0%Mar 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Mar 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 366 | 339 | 351 | 394 | 404 | 416 | 418 | 440 | 470 | 462 | 466 | 489 | 578 |
| Expenses + | 311 | 289 | 306 | 356 | 354 | 359 | 362 | 389 | 409 | 404 | 405 | 428 | 497 |
| Operating Profit | 55 | 50 | 45 | 38 | 51 | 57 | 56 | 51 | 60 | 58 | 61 | 62 | 81 |
| OPM % | 15% | 15% | 13% | 10% | 13% | 14% | 13% | 12% | 13% | 13% | 13% | 13% | 14% |
| Other Income + | 1 | 2 | 0 | 1 | 2 | 2 | 1 | 5 | 2 | 4 | 3 | 7 | 7 |
| Interest | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| Depreciation | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 7 | 7 | 8 |
| Profit before tax | 49 | 47 | 40 | 32 | 45 | 52 | 50 | 49 | 54 | 54 | 55 | 61 | 80 |
| Tax % | 26% | 25% | 25% | 25% | 26% | 25% | 26% | 30% | 23% | 26% | 26% | 26% | 26% |
| Net Profit + | 37 | 35 | 30 | 24 | 34 | 39 | 37 | 35 | 42 | 40 | 41 | 45 | 59 |
| EPS in Rs | 30.24 | 28.93 | 24.44 | 20.09 | 27.70 | 32.26 | 30.77 | 28.60 | 34.60 | 32.86 | 30.36 | 33.33 | 43.65 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended June 30, 2026 And Recommend Final Dividend For The FY Ended March 31, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018